D, Y., S, W., M, S., Y, J., M, S., J, K., . . . M, M. (2024). An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity. Pharmaceutics, 16(2), . https://doi.org/10.3390/pharmaceutics16020158
Chicago Style (17th ed.) CitationD, Yu, et al. "An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity." Pharmaceutics 16, no. 2 (2024). https://doi.org/10.3390/pharmaceutics16020158.
MLA (9th ed.) CitationD, Yu, et al. "An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity." Pharmaceutics, vol. 16, no. 2, 2024, https://doi.org/10.3390/pharmaceutics16020158.